We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Device Recall Oversight Needs Reform, GAO Says
The FDA should launch a program to routinely and systematically assess device recall information, and use this to identify strategies for mitigating health risks presented by defective or unsafe devices, the Government Accountability Office (GAO) says.